Myron Kaplan, Director at CorMedix Inc. (CRMD), bought 25,000 shares at $11.02 ($276K) on 2025-10-23, disclosed to the SEC on 2025-10-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CRMD | BUY | 2021-11-19 | $51K | — | Filing → |
| CRMD | BUY | 2021-05-19 | $90K | — | Filing → |
| CRMD | BUY | 2020-09-04 | $131K | — | Filing → |